ALAB Stands Out as the Week's Deepest Decline Among Semiconductor Peers

Among its closest semiconductor peers, ALAB is the outlier this week, and not in a flattering way. While LSCC slipped 3%, LRCX fell 4.2%, and AMD dropped 12%, Astera Labs lost 18.5% over the same five sessions, nearly five times the peer-group median of roughly 3.8%. The stock closed at $233.62 on Tuesday, down 33% over the past month, a selloff that now has it trading well below the consensus analyst price target of $387.57.

Short interest, in this context, tells a quieter story. Positions have fallen to their lowest level in over a year, now at 4.75% of free float, with the decline accelerating: shorts retreated 10.9% over the past week and are down 14.5% over the past month. The borrow market is loose, with availability at 7,654%, meaning there are roughly 77 shares available to lend for every one currently borrowed. That figure has expanded sharply from September levels when availability was closer to 1,988%. Cost to borrow, at 0.50%, remains negligible despite edging up 43% over the past month in absolute terms. The divergence between the stock's steep decline and the retreat in short exposure is notable: this is not a short-driven selloff.

Insider activity runs in the same direction as short covering, though with less conviction. The 90-day net activity amounts to roughly $90 million in net selling, the bulk from director Stefan Dyckerhoff's planned disposals under a 10b5-1 programme, which carry limited informational weight. FMR LLC filed a fresh 13G on October 7, disclosing a 9.1% stake, the largest on the register. BlackRock also added shares in its most recent filing, raising its holding to 7.4% of the class. These are passive accumulations, not activist positions; no Schedule 13D filer appears on the register.

The analytical community remains broadly constructive despite the selloff. Ten of ten analysts carry buy-equivalent ratings, and the most recent target-price action of consequence came from TD Cowen in mid-October, which cut its target from $375 to $300 while keeping a Hold. That move came after a quarter when most of the Street was raising targets aggressively: Morgan Stanley went to $382, RBC to $500, and Evercore to $452, all following the August print. The bull case rests on Astera's position in PCIe Gen 6 and its Scorpio-X volume ramp, which should widen average selling prices and support the 76% gross margins the company posted in Q1. Bears point to AWS warrant concentration, rising competition from Broadcom and Marvell in retimers, and the possibility that hyperscaler capex moderates before Scorpio volumes scale to offset mix headwinds. Wikipedia attention is running nearly two standard deviations above its own 90-day average, a sign that retail interest in the name has picked up sharply into the print.

Tonight's report will test whether the August quarter's $308 million revenue and the guidance trajectory toward $360 million have held, and whether gross margin can remain above 75% as product mix shifts toward newer platforms.